{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:14:40Z","timestamp":1793146480846,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jphs.2021.09.009","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T21:39:28Z","timestamp":1633642768000},"page":"86-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of dapagliflozin on peripheral sympathetic nerve activity in standard chow- and high-fat-fed rats after a glucose load"],"prefix":"10.1016","volume":"148","author":[{"given":"Daisuke","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jota","family":"Amarume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuna","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuyoshi","family":"Nishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonggang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Kusunoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2021.09.009_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/hr.2017.14","article-title":"Arterial pressure lability is improved by sodium-glucose cotransporter 2 inhibitor in streptozotocin-induced diabetic rats","volume":"40","author":"Yoshikawa","year":"2017","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jphs.2021.09.009_bib2","first-page":"471","article-title":"A\u00a0new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity","volume":"71","author":"Sano","year":"2018","journal-title":"J\u00a0Cardiol"},{"key":"10.1016\/j.jphs.2021.09.009_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41440-020-0410-8","article-title":"Effects of an SGLT2 inhibitor on the salt sensitivity of blood pressure and sympathetic nerve activity in a nondiabetic rat model of chronic kidney disease","volume":"43","author":"Wan","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jphs.2021.09.009_bib4","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2021.09.009_bib5","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1185\/03007995.2014.912983","article-title":"Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled, phase 3 study","volume":"30","author":"Seino","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jphs.2021.09.009_bib6","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jphs.2021.09.009_bib7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1177\/1479164115585298","article-title":"Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes","volume":"12","author":"Sj\u00f6str\u00f6m","year":"2015","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/j.jphs.2021.09.009_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jash.2014.02.003","article-title":"Blood pressure effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors","volume":"8","author":"Oliva","year":"2014","journal-title":"J\u00a0Am Soc Hypertens"},{"key":"10.1016\/j.jphs.2021.09.009_bib9","doi-asserted-by":"crossref","first-page":"e0150756","DOI":"10.1371\/journal.pone.0150756","article-title":"Dapagliflozin, a sodium-glucose co-transporter 2 inhibitor, acutely reduces energy expenditure in BAT via neural signals in mice","volume":"11","author":"Chiba","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2021.09.009_bib10","first-page":"E298","article-title":"Ventromedial hypothalamic stimulation enhances peripheral glucose uptake in anesthetized rats","volume":"261","author":"Sudo","year":"1991","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jphs.2021.09.009_bib11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10047-013-0700-x","article-title":"Effects of electrical microstimulation of peripheral sympathetic nervous fascicle on glucose uptake in rats","volume":"16","author":"Sato","year":"2013","journal-title":"J\u00a0Artif Organs"},{"issue":"suppl. 1","key":"10.1016\/j.jphs.2021.09.009_bib12","first-page":"A456","article-title":"Electrical stimulation of peripheral sympathetic nerve fascicle enhances non-insulin-mediated glucose uptake in rats","volume":"65","author":"Sato","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2021.09.009_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production","volume":"124","author":"Merovci","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jphs.2021.09.009_bib14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.metabol.2015.10.010","article-title":"The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db\/db mice both as monotherapy and in combination with linagliptin","volume":"65","author":"Kern","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.jphs.2021.09.009_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ejphar.2014.01.040","article-title":"SGLT2 selective inhibitor ipragliflozin reduces body fat mass by increasing fatty acid oxidation in high-fat diet-induced obese rats","volume":"727","author":"Yokono","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2021.09.009_bib16","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1172\/JCI115260","article-title":"Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans","volume":"87","author":"Anderson","year":"1991","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jphs.2021.09.009_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3945\/ajcn.2008.26299","article-title":"Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome","volume":"89","author":"Straznicky","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jphs.2021.09.009_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.autneu.2013.06.005","article-title":"Characteristics of spike rate of peripheral sympathetic nervous signal in streptozotocin-induced diabetic rats","volume":"179","author":"Shinzawa","year":"2013","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jphs.2021.09.009_bib19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.metabol.2011.05.012","article-title":"Site dependency of fatty acid composition in adipose triacylglycerol in rats and its absence as a result of high-fat feeding","volume":"61","author":"Sato","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.jphs.2021.09.009_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2016.01.012","article-title":"PPAR\u03b3 activation alters fatty acid composition in adipose triglyceride, in addition to proliferation of small adipocytes, in insulin resistant high-fat fed rats","volume":"773","author":"Sato","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2021.09.009_bib21","doi-asserted-by":"crossref","first-page":"H1360","DOI":"10.1152\/ajpheart.00181.2016","article-title":"Effects of various types of anesthesia on hemodynamics, cardiac function, and glucose and lipid metabolism in rats","volume":"311","author":"Sano","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jphs.2021.09.009_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0165-0270(03)00234-6","article-title":"Microneurography in anesthetized rats for the measurement of sympathetic nerve activity in the sciatic nerve","volume":"131","author":"Nakamura","year":"2003","journal-title":"J\u00a0Neurosci Methods"},{"key":"10.1016\/j.jphs.2021.09.009_bib23","doi-asserted-by":"crossref","first-page":"E414","DOI":"10.1152\/ajpendo.00545.2012","article-title":"Selective SGLT2 inhibition by tofogliflozin reduces renal glucose reabsorption under hyperglycemic but not under hypo- or euglycemic conditions in rats","volume":"304","author":"Nagata","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jphs.2021.09.009_bib24","first-page":"E167","article-title":"Muscle glucose uptake during and after exercise is normal in insulin-resistant rats","volume":"264","author":"Kusunoki","year":"1993","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jphs.2021.09.009_bib25","doi-asserted-by":"crossref","first-page":"E1231","DOI":"10.1152\/ajpendo.00173.2001","article-title":"Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats","volume":"282","author":"Chalkley","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jphs.2021.09.009_bib26","first-page":"353","article-title":"Sympathetic microneurography","volume":"ume 117","author":"Macefield","year":"2013"},{"key":"10.1016\/j.jphs.2021.09.009_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1109\/TBME.2002.807323","article-title":"Analysis of raw microneurographic recordings based on wavelet de-noising technique and classification algorithm: wavelet analysis in microneurography","volume":"50","author":"Diedrich","year":"2003","journal-title":"IEEE Trans Biomed Eng"},{"key":"10.1016\/j.jphs.2021.09.009_bib28","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/00325481.2016.1153941","article-title":"Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials","volume":"128","author":"Johnsson","year":"2016","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jphs.2021.09.009_bib29","first-page":"e14360","article-title":"Osmotic diuresis by SGLT2 inhibition stimulates vasopressin-induced water reabsorption to maintain body fluid volume","volume":"8","author":"Masuda","year":"2020","journal-title":"Phys Rep"},{"key":"10.1016\/j.jphs.2021.09.009_bib30","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/oby.2012.59","article-title":"Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats","volume":"20","author":"Devenny","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/j.jphs.2021.09.009_bib31","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1507\/endocrj.EJ19-0013","article-title":"Effects of sodium-glucose cotransporter 2 inhibitor (dapagliflozin) on food intake and plasma fibroblast growth factor 21 levels in type 2 diabetes patients","volume":"66","author":"Kosugi","year":"2019","journal-title":"Endocr J"},{"key":"10.1016\/j.jphs.2021.09.009_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s10286-014-0235-0","article-title":"Relationship of muscle sympathetic nerve activity to insulin sensitivity","volume":"24","author":"Curry","year":"2014","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jphs.2021.09.009_bib33","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/HYPERTENSIONAHA.112.201301","article-title":"High-fat food, sympathetic nerve activity, and hypertension: danger soon after the first bite?","volume":"60","author":"Brooks","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jphs.2021.09.009_bib34","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1002\/ehf2.12825","article-title":"Rationale and design of the EMPYREAN study","volume":"7","author":"Motoki","year":"2020","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jphs.2021.09.009_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.autneu.2015.08.005","article-title":"Effects of aldose reductase inhibitor on microneurographically assessed peripheral sympathetic nerve activity in rats","volume":"193","author":"Sato","year":"2015","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.jphs.2021.09.009_bib36","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.molmet.2017.07.005","article-title":"Reduced renal sympathetic nerve activity contributes to elevated glycosuria and improved glucose tolerance in hypothalamus-specific Pomc knockout mice","volume":"6","author":"Chhabra","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/j.jphs.2021.09.009_bib37","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s00125-015-3771-9","article-title":"Role of the renal sympathetic nerve in renal glucose metabolism during the development of type 2 diabetes in rats","volume":"58","author":"Rafiq","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.jphs.2021.09.009_bib38","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2337\/db15-0804","article-title":"Hypothalamic POMC deficiency improves glucose tolerance despite insulin resistance by increasing glycosuria","volume":"65","author":"Chhabra","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.jphs.2021.09.009_bib39","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00125-020-05289-z","article-title":"Hypothalamic MC4R regulates glucose homeostasis through adrenaline-mediated control of glucose reabsorption via renal GLUT2 in mice","volume":"64","author":"de Souza Cordeiro","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.jphs.2021.09.009_bib40","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s00125-019-4819-z","article-title":"Empagliflozin enhances human and murine cardiomyocyte glucose uptake by increased expression of GLUT1","volume":"62","author":"Mustroph","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jphs.2021.09.009_bib41","doi-asserted-by":"crossref","first-page":"14875","DOI":"10.1073\/pnas.1004282107","article-title":"Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity","volume":"107","author":"Horvath","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jphs.2021.09.009_bib42","doi-asserted-by":"crossref","first-page":"29290","DOI":"10.1038\/srep29290","article-title":"Defective regulation of POMC precedes hypothalamic inflammation in diet-induced obesity","volume":"6","author":"Souza","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.jphs.2021.09.009_bib43","doi-asserted-by":"crossref","first-page":"101114","DOI":"10.1016\/j.isci.2020.101114","article-title":"Selective survival of Sim1\/MC4R neurons in diet-induced obesity","volume":"23","author":"Nyamugenda","year":"2020","journal-title":"iScience"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861321000955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:02:15Z","timestamp":1761163335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861321000955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1347861321000955"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2021.09.009","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of dapagliflozin on peripheral sympathetic nerve activity in standard chow- and high-fat-fed rats after a glucose load","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2021.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}